New strategy for transfection: mixtures of medium-chain and long-chain cationic lipids synergistically enhance transfection

被引:0
作者
L Wang
R C MacDonald
机构
[1] Molecular Biology and Cell Biology,Department of Biochemistry
[2] Northwestern University,undefined
来源
Gene Therapy | 2004年 / 11卷
关键词
HUAEC; lipofection; lipoplex;
D O I
暂无
中图分类号
学科分类号
摘要
To date, the primary approach to improve the transfection properties of cationic lipids has been the synthesis of new kinds of cationic amphipaths or the inclusion of noncationic helper lipids. Here, it is reported that an alternative approach can be unusually effective, namely, the combination of two cationic lipid derivatives having the same head group but tails of different chain lengths. Particularly efficient was the combination of dilauroyl (12 carbon chain) and dioleoyl (18 carbon chain) homologues of O-ethylphosphatidylcholine. This mixture transfected DNA into human umbilical artery endothelial cells (HUAEC) more than 30-fold more efficiently than either compound separately. A unique advantage of this kind of combination agent is that transfection can be optimized either in the presence or absence of serum by adjusting the component ratio.
引用
收藏
页码:1358 / 1362
页数:4
相关论文
共 36 条
[1]  
Koning GA(2002)Endothelial cells at inflammatory sites as target for therapeutic intervention Endothelium 9 161-171
[2]  
Schiffelers RM(2000)Tumour necrosis factor-alpha gene expression and production in human umbilical arterial endothelial cells Clin Sci 98 461-470
[3]  
Storm G(2000)Identification of syntenin and other TNF-inducible genes in human umbilical arterial endothelial cells by suppression subtractive hybridization FEBS Lett 467 299-304
[4]  
Neuhaus T(2002)Endothelial function. From vascular biology to clinical applications Am J Cardiol 90 40L-48L
[5]  
Stier S(2002)Vitamin C and vitamin E antagonistically modulate human vascular endothelial and smooth muscle cell DNA synthesis and proliferation Eur J Nutr 41 27-34
[6]  
Behrendt D(2003)A targeted approach for antiangiogenic therapy of metastatic human colon cancer Am Surg 69 3-10
[7]  
Ganz P(2003)Current targets for anticancer drug discovery Curr Drug Targets 4 159-179
[8]  
Ulrich-Merzenich G(2001)Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy Curr Drug Targets Immune Endocr Metabol Disord 1 241-253
[9]  
Metzner C(2002)Angiogenic gene therapy Drugs Today (Barc) 38 819-827
[10]  
Schiermeyer B(2002)Development and use of gene transfer for treatment of cardiovascular disease J Card Surg 17 543-548